Investigational Drug Promising in Obese Patients With Diabetes Investigational Drug Promising in Obese Patients With Diabetes
An investigational agent originally developed for sarcopenia has shown promise in a phase 2 trial in those with obesity and type 2 diabetes, leading to a loss of body fat as well as weight reduction.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | Obesity